Wordt geladen...
Proof of Concept: First Pediatric [(14)C]microtracer Study to Create Metabolite Profiles of Midazolam
Growth and development affect drug‐metabolizing enzyme activity thus could alter the metabolic profile of a drug. Traditional studies to create metabolite profiles and study the routes of excretion are unethical in children due to the high radioactive burden. To overcome this challenge, we aimed to...
Bewaard in:
| Gepubliceerd in: | Clin Pharmacol Ther |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689753/ https://ncbi.nlm.nih.gov/pubmed/32386327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1884 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|